Connect with us

Business Partnerships

Tobacco Kingpin Imperial Brands Invests Over $120 Million into Auxly Cannabis to Create Vape Products

Jane Summers



Tobacco Kingpin Imperial Brands Invests Over $120 Million into Auxly Cannabis to Create Vape Products
- Ad -

Giant Imperial Brands, a British Tobacco company, is taking strides into the cannabis industry. Specifically, the company will be investing $123 million into Auxly Cannabis Group, Inc. The investment will not only promote the partnership, but also research and development. Further, Auxly will have access to Imperials license for vaping technology.

The move was announced in a press release by Auxly, in which it states that it is welcoming the investment and R&D partnership with Imperial Brands.

Hugo Alves, Auxly’s President, shared in the press release,

“This investment from Imperial Brands will enhance Auxly’s ability to continue to deliver on our business plans and accelerate our growth initiatives to expand our portfolio of branded derivative products. The timing is ideal as we prepare to bring our portfolio of innovative cannabis products to the Canadian market following the legalization of edibles, extracts and topicals later this year.”

Auxly’s Chairman and CEO also shared, Chuck Rifici, also shared,

“Following its extensive evaluation of the Canadian cannabis market, we’re thrilled that Imperial Brands selected Auxly as its partner of choice due to the high calibre of our assets, people and capabilities. We are particularly excited to partner with Imperial Brands on current and future intellectual property and product development, starting with immediate access to its portfolio of vaping technologies and research and development capabilities.”

The partnership will also allow Auxly to move ahead with its business plans as Canada’s CBD business market makes big changes. Those who are interested in reading the full press release can do so here.

According to a news report by Quartz, “Many of the cannabis industry’s titans are based in Canada, where they enjoy nation-wide legalization.” In the United States, marijuana is illegal under federal law and is classified as a Schedule I substance.

All information is for general informational and educational purposes only. Nothing should be interpreted as legal or wellness advice.

Jane is a regular contributor who learned about the great benefits of CBD a few years ago after starting it herself. Impressed by its effects, she's interested in helping others learn about options that can be helpful for them.

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email

Copyright © 2020 | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.